id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-351407-7vx9lzi0	Mehta, Puja	JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk	2020-07-06		.txt	text/plain	1252	45	24	We recommend risk mitigation strategies including consideration of exclusion of patients with high thrombotic risk, treatment with standard or intermediate-dose low molecular weight heparin prophlyaxis 7 during hospitalisation and consideration of increased thrombotic risk associated with JAKi, given the hypercoagulability of COVID-19. Although it was initially thought that insidious venous thromboembolic events (VTE) were mainly confined to ventilated patients [3], we now understand thrombotic risk to be a wider problem in COVID-19.	cache/cord-351407-7vx9lzi0.txt	txt/cord-351407-7vx9lzi0.txt
